Stock Events

Stock Events

Allogene Therapeutics (ALLO) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.29

-0.25

-0.22

-0.18

Details

Expected EPS

-0.190122

Actual EPS

-0.18

Surprise EPS

0.01

Surprise Percent

+5.32%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.18 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.